Clinical trial Recruiting at 1 site Interventional Ages 6 Months to 7

Parasternal plane block to reduce pain signals during pediatric median sternotomy

Official title: Effect of Parasternal Plane Block on Intraoperative Nociception in Pediatric Cardiac Surgery

Run by Diskapi Yildirim Beyazit Education and Research Hospital · NCT07354750 · Data updated 2026-11-12

This will test whether an ultrasound-guided parasternal plane block can reduce intraoperative pain signals in children aged 6 months to 7 years undergoing heart surgery with a median sternotomy.

More Pain Management trials

Quick facts

Study typeInterventional
Ages6 Months to 7 Years
SexAll
Enrollment60 (estimated)
SponsorDiskapi Yildirim Beyazit Education and Research Hospital
Government
Locations1 site (Ankara)
StatusRecruiting
StartedJanuary 30, 2026
Main results expectedAugust 3, 2026
Study endsAugust 17, 2026
Registry record updatedFebruary 2, 2026
Trial IDNCT07354750 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 6 months to 7 years scheduled for elective congenital cardiac surgery with planned median sternotomy, ASA physical status II–III, hemodynamically stable, and with parent or guardian consent are eligible.

Probably not a fit

Patients undergoing emergency or redo sternotomy, those outside the 6 months–7 years age range, ASA I or >III, with severe neurological disorders, or without parental consent are unlikely to qualify or benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized trial in pediatric patients undergoing elective congenital cardiac surgery via median sternotomy that compares ultrasound-guided parasternal plane block to no peripheral nerve block. Intraoperative nociception will be measured objectively using the Pain Index Monitor (PAM), which records skin conductance changes, alongside routine hemodynamic monitoring. The protocol records opioid requirements, hemodynamic stability, and markers of recovery such as time to extubation and ICU course. The trial aims to determine whether adding the parasternal plane block meaningfully lowers nociceptive signals and related clinical endpoints during surgery.

Why it matters

Potential benefit: If successful, the block could lower intraoperative nociception, reduce opioid needs, and improve perioperative stability and recovery for children having median sternotomy.

How similar studies have gone: Regional parasternal/pectoral plane blocks have shown promise in adult and pediatric case series for reducing postoperative pain, but randomized data using objective intraoperative nociception monitors are still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 6 months and 7 years
* Scheduled for elective congenital cardiac surgery
* Planned median sternotomy
* American Society of Anesthesiologists (ASA) physical status II-III
* Hemodynamically stable preoperative condition
* Written informed consent obtained from a parent or legal guardian

Exclusion Criteria:

* Emergency surgery or redo sternotomy
* Age \<6 months or \>7 years
* ASA physical status I or \>III
* Severe neurological disorders preventing reliable application of behavioral pain scales
* Failure to obtain written informed consent from a parent or legal guardian

Where it's running

  • Ankara Etlik City Hospital
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.